Charlotte Leleu is a Partner and Head of the Toulouse office at Plasseraud IP. She is a French and European Patent Attorney. Charlotte advises clients on the protection and defense of their patent portfolio, as well as on the definition and implementation of intellectual property strategies. With a strong background in applied mathematics and computer-implemented inventions, she has developed particular expertise in the field of “Big Data” and Artificial Intelligence.

Jean-Marc Coquel is a Partner and Head of Bordeaux and Angoulême Offices at Plasseraud IP. He is a French and European Patent Attorney. Jean-Marc coordinates the group’s business in the region of Aquitaine. With more than 20 years of experience, he advises clients on developing and implementing their intellectual property strategy in the fields of mechanics, physics and optics.

Nathalie is a Partner and a Patent Attorney at Plasseraud IP. She works on cases relating to cosmetics, pharmaceuticals, polymers, petrochemicals and catalysis for individuals, companies and research institutes. With more than 15 years of experience in intellectual property, she advises individuals, large groups and research institutes in the development and management of their patent portfolios: patent applications, granting procedures, legal advice (freedom to operate, audit of IP portfolios) and valuation, in the chemical sectors.

Denis Bourgarel is a Partner and Patent Attorney at Plasseraud IP. 

Catherine Touati is a Partner and a Patent Attorney at Plasseraud IP. She is involved in the fields of chemistry, cosmetics, food processing, and more specifically in pharmaceuticals and phytopharmacy. She deals with case files, conducts freedom of operation studies and manages litigation files. She has developed a particular expertise in Supplementary Protection Certificates (SPC) and Plant Variety Rights (PVR). She joined Plasseraud IP in 1996, after a first four-year experience in an IP law firm, where she trained in patent and trademark law. She became a Partner in 2011.

Frédéric Niemann is a Partner and Patent Attorney at Plasseraud IP. He is active in the fields of biotechnology, pharmaceuticals, chemistry and medtech. He was an examiner at the European Patent Office from 2000 to 2005 (in The Hague). He was specialized in the fields of biotechnology (gene therapy, vaccines, and diagnostics). Frédéric joined Plasseraud IP in 2005.

Raphaël Fleurance is a Partner and Head of the Lyon office at Plasseraud IP. He is a French and European Patent and Trademark Attorney. He works in the areas of chemistry, physics and medtech, for the drafting, prosecution and defense of patents, trademarks and designs, as well as IP contracts. He began his career in the Direction Générale de l’Armement for a year. Then, he moved to the IP department of Salomon (sport equipments) in 1986/1987 and afterwards he worked for three years at the IP department of Roquette Frères, a leading multinational firm in the agrochemical industry.

Bertrand Loisel is a member of Plasseraud IP's Executive Committee. 

An Industrial Property Attorney and European Patent Attorney, he heads the firm's Mechanics-Electronics-Computing department. He supports major players and innovative companies in the IT, telecoms and construction sectors in their industrial property strategy, in the technical fields of mechanics, IT and electricity. He advises and litigates, representing clients in oppositions before the European Patent Office, and in infringement cases before French and foreign courts. 

Cyra Nargolwalla is a member of Plasseraud IP's Executive Committee. She began her career in IP at Plasseraud IP in 1994, and became a Partner in 2004. She specializes in biotechnology and pharmaceuticals (including vaccines, hormone therapy and cancer treatment), as well as in the textile, paper and food industries. She regularly represents clients in oral opposition and appeal proceedings before the EPO. She also handles litigation files for French and foreign clients. She regularly lectures on subjects relating to biotechnology/pharmaceutical patents and litigation.